{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:50:17Z","timestamp":1790787017057,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1105089"],"award-info":[{"award-number":["1105089"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156072"],"award-info":[{"award-number":["1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2017131"],"award-info":[{"award-number":["2017131"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195651"],"award-info":[{"award-number":["1195651"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jad.2024.02.052","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T17:39:14Z","timestamp":1708277954000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)"],"prefix":"10.1016","volume":"352","author":[{"given":"Donel M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Baune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Glozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Glue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Hadzi-Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen K.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.02.052_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2020.01.002","article-title":"Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients","volume":"123","author":"Basso","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.02.052_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.psychres.2018.08.033","article-title":"The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review","volume":"269","author":"Cambridge","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.02.052_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1037\/0894-4105.7.1.41","article-title":"Neurocognitive outcome after endoscopic third ventriculocisterostomy in patients with obstructive hydrocephalus","volume":"7","author":"Chelune","year":"1993","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jad.2024.02.052_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2018.07.033","article-title":"Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion","volume":"241","author":"Chen","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2024.02.052_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/13854046.2016.1256435","article-title":"Reliability and validity of the CogState computerized battery in patients with seizure disorders and healthy young adults: comparison with standard neuropsychological tests","volume":"31","author":"Fratti","year":"2017","journal-title":"Clin. Neuropsychol."},{"issue":"4","key":"10.1016\/j.jad.2024.02.052_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/arclin\/acaa076","article-title":"An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: research and clinical implications","volume":"36","author":"Gates","year":"2021","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"8","key":"10.1016\/j.jad.2024.02.052_bb0035","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/pm\/pnv112","article-title":"The effects of long-term ketamine treatment on cognitive function in complex regional pain syndrome: a preliminary study","volume":"17","author":"Kim","year":"2016","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.jad.2024.02.052_bb0040","doi-asserted-by":"crossref","first-page":"20935","DOI":"10.4088\/JCP.18m12472","article-title":"Cognitive deficits in the THINC-integrated tool (THINC-it) are associated with psychosocial dysfunction in patients with major depressive disorder","volume":"80","author":"Knight","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.052_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2019.08.012","article-title":"Repeated intravenous infusions of ketamine: neurocognition in patients with anxious and nonanxious treatment-resistant depression","volume":"259","author":"Liu","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2024.02.052_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.02.052_bb0055","article-title":"Efficacy and safety of a 4-0week course of repeated subcutaneous ketamine injection for treatment-resistant depression \u2013 the KADS study: a randomised, double-blind, active-controlled trial","volume":"1-9","author":"Loo","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.02.052_bb0060","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2020.65","article-title":"Is cognitive dysfunction involved in difficult-to-treat depression? Characterizing resistance from a cognitive perspective","volume":"63","author":"Lopez-Sola","year":"2020","journal-title":"Eur. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2024.02.052_bb0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/YCT.0000000000000687","article-title":"A comparison of computerized versus pen-and-paper cognitive tests for monitoring electroconvulsive therapy\u2013related cognitive side effects","volume":"36","author":"Martin","year":"2020","journal-title":"J. ECT"},{"issue":"6","key":"10.1016\/j.jad.2024.02.052_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1037\/neu0000626","article-title":"Neurocognitive subgroups in major depressive disorder","volume":"34","author":"Martin","year":"2020","journal-title":"Neuropsychology"},{"issue":"2","key":"10.1016\/j.jad.2024.02.052_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/arclin\/acp010","article-title":"Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex","volume":"24","author":"Maruff","year":"2009","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.jad.2024.02.052_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jad.2024.02.052_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jalz.2014.09.001","article-title":"Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging","volume":"10","author":"Mielke","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.jad.2024.02.052_bb0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.02.052_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2024.02.052_bb0100","first-page":"149","article-title":"Long-term heavy ketamine use is associated with spatial memory impairment and altered hippocampal activation","volume":"5","author":"Morgan","year":"2014","journal-title":"Front. Psych."},{"issue":"10","key":"10.1016\/j.jad.2024.02.052_bb0105","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2024.02.052_bb0110","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/npp.2014.298","article-title":"Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial","volume":"40","author":"Murrough","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2024.02.052_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jagp.2019.10.008","article-title":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression\u2014TRANSFORM-3","volume":"28","author":"Ochs-Ross","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2024.02.052_bb0120","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S1461145714001011","article-title":"Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression","volume":"17","author":"Shiroma","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2024.02.052_bb0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41398-020-00897-0","article-title":"A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression","volume":"10","author":"Shiroma","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.052_bb0130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jad.2020.01.120","article-title":"Development of the ketamine side effect tool (KSET)","volume":"266","author":"Short","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2024.02.052_bb0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/104012371402600310","article-title":"Defining treatment-resistant depression: a comprehensive review of the literature","volume":"26","author":"Trevino","year":"2014","journal-title":"Annual Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.02.052_bb0140","doi-asserted-by":"crossref","first-page":"38984","DOI":"10.4088\/JCP.21r13870","article-title":"The effects of ketamine on cognition in unipolar and bipolar depression: a systematic review","volume":"83","author":"Vaccarino","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2024.02.052_bb0145","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.02.052_bb0150","series-title":"Depression and Other Common Mental Disorders","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.jad.2024.02.052_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.02.052_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jad.2018.12.005","article-title":"Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder","volume":"246","author":"Zheng","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.jad.2024.02.052_bb0165","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0269881118798614","article-title":"Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression","volume":"32","author":"Zhou","year":"2018","journal-title":"J. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724003616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724003616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:08:35Z","timestamp":1781928515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724003616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S0165032724003616"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.02.052","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.02.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}